健友股份:子公司获美国FDA硫酸阿米卡星注射液生产场地批件

同花顺
Sep 22

9月22日,健友股份(603707)(603707.SH)公告称,公司子公司Meitheal Pharmaceuticals Inc.近日收到美国FDA签发的硫酸阿米卡星注射液(500mg/2mL、1g/4mL)增加生产场地的批件,批准在南京健友生化制药股份有限公司场地生产。该产品用于短期治疗敏感革兰阴性菌所致严重感染,本次获批进一步丰富公司国际化产品管线,强化国际市场布局,后续若推进美国市场上市...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10